STOK•benzinga•
Stoke Therapeutics CEO Edward Kaye To Step Down; Director Ian Smith Appointed As Interim CEO And Arthur Tzianabos Appointed As Interim Executive Chairman
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on March 18, 2025 by benzinga